PCSK9i: proprotein convertase subtilisin/kexin type 9 inhibitor a new phase of lipid-lowering treatment
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2023.
| Автор: | |
|---|---|
| Інші автори: | |
| Формат: | Дисертація |
| Мова: | English |
| Опубліковано: |
Brac University
2024
|
| Предмети: | |
| Онлайн доступ: | http://hdl.handle.net/10361/23252 |